12:00 AM
Sep 01, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Alpharadin: Phase II data

In the double-blind, European Phase II BC1-03 trial in 100 HRPC patients, IV Alpharadin provided a dose-dependent increase in pain relief. Patients were administered single doses of 5, 25, 50 or 100...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >